- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about NVAX
Recent news which mentions NVAX
Nasdaq, S&P 500 Futures Flatline Ahead Of Housing, Consumer Data: Analyst Pins Hopes On Dollar, Fed Rates To Keep Flickering Rally Hopes Alive
February 28, 2023
From Benzinga
Earnings Scheduled For February 28, 2023
February 28, 2023
From Benzinga
From Motley Fool
2 Beaten-Down Stocks That Might Be too Cheap to Ignore
February 22, 2023
From Motley Fool
More Likely to 5x First: Novavax vs. Ocugen
February 16, 2023
From Motley Fool
Is This the Telltale Sign to Sell Novavax Stock?
February 14, 2023
From Motley Fool
NYC Mayor Eric Adams says vaccine mandates could return because COVID ‘isn’t going away’
February 13, 2023
Tickers
NVAX
Tags
NVAX
From MarketWatch
Why Is Monday.com (MNDY) Stock Up 11% Today?
February 13, 2023
From InvestorPlace
NVAX Stock Alert: Novavax Will Provide 1.5 Million More Covid-19 Vaccine Doses to U.S.
February 13, 2023
From InvestorPlace
These Cheap Growth Stocks Could Supercharge Your Portfolio
February 12, 2023
From Motley Fool
Is Novavax Stock a Buy With the New Normal for COVID?
February 10, 2023
From Motley Fool
Better Buy: Novavax or BioNTech Stock?
February 04, 2023
From Motley Fool
3 Sorry Pharma Stocks to Sell in February Before It’s Too Late
February 01, 2023
From InvestorPlace
1 Reason to Buy Novavax in 2023 and 2 Reasons to Sell
February 01, 2023
From Motley Fool
$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns
January 30, 2023
From Benzinga
3 Great Growth Stocks Down 20% or More to Buy Now
January 27, 2023
From Motley Fool
Tickers
NVAX
From Motley Fool
3 Remarkable Stocks That Can Burn Short-Sellers Big-Time in 2023
January 24, 2023
From Motley Fool
Here's the Worst Mistake Novavax Investors Can Make in 2023
January 20, 2023
From Motley Fool
China to start issuing new tourism passports as Lunar New Year approaches amid wave of COVID cases
January 18, 2023
Tickers
NVAX
From MarketWatch
3 Biotech Stocks Under $15 Worth a Second Look in 2023
January 18, 2023
From Motley Fool
Pfizer (PFE) Stock Falls on Analyst Downgrade
January 17, 2023
From InvestorPlace
2 Down-on-Their-Luck Stocks That Could Go Parabolic
January 17, 2023
From Motley Fool
From Motley Fool
Tickers
NVAX
From Motley Fool
With This Big Transition Ahead, Is Novavax a Buy?
January 12, 2023
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.